Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Powell

Showing results (851-860 of 864) with videos related to

Pageof 87
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|July 14, 2004
Pancreaticoduodenectomy: a 20-year experience in 516 patientsC Max Schmidt, Emilie S Powell, Constantin T Yiannoutsos, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 28, 2017
A portable magneto-optical trap with prospects for atom interferometry in civil engineeringA Hinton, M Perea-Ortiz, J Winch, et al.
The British Journal of Dermatology|September 13, 2006
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study groupA M Bryden, H Moseley, S H Ibbotson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia AVincent P Diego, Bernadette W Luu, Marco Hofmann, et al.
Frontiers in Genetics|April 24, 2025
Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia AVincent P Diego, Bernadette W Luu, Marcio A Almeida, et al.
Peerj|June 27, 2025
A predictive framework for identifying source populations of non-native marine macroalgae: <i>Chondria tumulosa</i> in the Pacific OceanJames T Fumo, Patrick K Nichols, Taylor Ely, et al.
Blood|November 15, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia AJohnny Mahlangu, Jerry S Powell, Margaret V Ragni, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 87

Showing results (851-860 of 864) with videos related to

Sort By:
Pageof 87
Archives of Surgery (Chicago, Ill. : 1960)|July 14, 2004
Pancreaticoduodenectomy: a 20-year experience in 516 patientsC Max Schmidt, Emilie S Powell, Constantin T Yiannoutsos, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 28, 2017
A portable magneto-optical trap with prospects for atom interferometry in civil engineeringA Hinton, M Perea-Ortiz, J Winch, et al.
The British Journal of Dermatology|September 13, 2006
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study groupA M Bryden, H Moseley, S H Ibbotson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia AVincent P Diego, Bernadette W Luu, Marco Hofmann, et al.
Frontiers in Genetics|April 24, 2025
Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia AVincent P Diego, Bernadette W Luu, Marcio A Almeida, et al.
Peerj|June 27, 2025
A predictive framework for identifying source populations of non-native marine macroalgae: <i>Chondria tumulosa</i> in the Pacific OceanJames T Fumo, Patrick K Nichols, Taylor Ely, et al.
Blood|November 15, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia AJohnny Mahlangu, Jerry S Powell, Margaret V Ragni, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 87